ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

Immunization standards

  WHO > Programmes and projects > Immunization standards > Vaccine quality
printable version

Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b (1 dose vial)

Vaccine Trade Name: Tritanrix HB+Hib

Vaccine Type: Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b

Manufacturer: GlaxoSmithKline

Country of Manufacture: Belgium

Date of prequalification: 16 May 2006

NRA of Record: Federal Agency for Medicines and Health Products

Product Description

Pharmaceutical form: Liquid

Presentation: 1 dose vial

Route of administration: intramuscular

Vaccine Vial Monitor: Type 30

Shelf life: 36 months at 2 - 8 °C

Secondary Packaging:

Cold Chain volume per dose (cm3):

Remarks

Image file of the primary container has not yet been supplied for publication by manufacturer.

Image file of the product insert has not yet been supplied for publication by the manufacturer. Click here to go to the multilingual text of the product insert.

[an error occurred while processing this directive]